30-270064-DMH_Opioid Antagonist
Open State & local contract opportunity Posted
- Solicitation number
- Doc2397329843
- State
- North Carolina
- Responses due
Opportunity facts
Opportunity details come from evp.nc.gov. Updated .
About this opportunity
The North Carolina Department of Health and Human Services, Division of Mental Health, Developmental Disabilities and Substance Use Services is requesting proposals for the purchase and shipping of opioid antagonist medications for distribution throughout North Carolina under RFP 30-270064-DMH, with proposals due October 23, 2026 at 2:00 PM ET.
The scope comprises 30,000 units of two-dose, ready-to-use intranasal opioid antagonist kits with applicators and 100,000 intramuscular opioid antagonist vials annually, along with up to 250 hours of technical assistance services per year. All costs must be fully burdened and inclusive of employment and administrative expenses, with shipping as FOB Destination to any valid address within North Carolina. Technical assistance services may not exceed 5% of actual product purchases. Delivery must be completed within 21 consecutive calendar days of purchase order receipt.
Vendors must demonstrate at least two years of experience in manufacturing and assembling intranasal or intramuscular opioid antagonist products within the United States, with direct shipping and distribution capability to multiple state governments. Vendors must also establish financial stability, maintain publicly accessible financial and operational information, and certify they have not been party to any settlements concerning misleading marketing of opioid antagonist products. All vendors must register with the North Carolina Secretary of State prior to contract award.
The contract carries an initial term of one year with State options to renew for up to three additional one-year terms. The State will evaluate proposals using a Best Value method with criteria in descending order of importance: Vendor Technical Approach, Vendor Qualifications, Vendor Experience and References, and Pricing. Written questions are due October 6, 2026 at 5:00 PM ET, and contract award is anticipated by December 15, 2027. The procurement is authorized under Session Law 2026-41, Senate Bill 257, Section IX-G, which mandates direct purchase from drug manufacturers using opioid settlement funds.
Opportunity text
The purpose of this Request for Proposal (RFP) is to obtain a Vendor(s) to partner with the North Carolina Department of Health and Human Services (NCDHHS), Division of Mental Health, Developmental Disabilities and Substance Use Services (DMH/DD/SUS or "Division") for the purchase and shipping of opioid antagonist medications within the State of North Carolina.From 2000-2024, more than 44,500 North Carolinians lost their lives to a drug overdose. Each day in 2024, 8 North Carolinians died from a drug overdose. Recent year death data is not yet final, but an estimated 2,731 North Carolinians (8 per day) are suspected to have died from an overdose in 2025.An opioid antagonist is a medication that binds to opioid receptors in the brain and blocks or reverses the effects of opioids such as heroin, fentanyl, oxycodone, morphine, and hydrocodone. It works quickly to restore normal breathing in someone experiencing an opioid overdose, which can prevent brain damage or death.The General Assembly of North Carolina, Session 2025, enacted Session Law 2026-41, Senate Bill 257. Section IX-G, Mental Health/Developmental Disabilities/Substance Use Services, Use of Opioid Settlement Funds which outlines the procurement of the following directly from drug manufacturers:a. Intranasal and intramuscular opioid antagonists for distribution to, or use by, persons or governmental entities engaged in opioid overdose prevention and response efforts within the State of North Carolina.b. Ancillary services related to the distribution and use of intranasal and intramuscular opioid
Files
On GovTribe
Work this opportunity
- Track it in your pipeline
- Similar opportunities
- Ask GovTribe AI about this opportunity